Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 625 entries
Sorted by: Best Match Show Resources per page
Use of mTOR inhibitors in the treatment of breast cancer: an evaluation of factors that influence patient outcomes.

Breast cancer (Dove Medical Press)

Jerusalem G, Rorive A, Collignon J.
PMID: 24833916
Breast Cancer (Dove Med Press). 2014 Apr 17;6:43-57. doi: 10.2147/BCTT.S38679. eCollection 2014.

Many systemic treatment options are available for advanced breast cancer, including endocrine therapy, chemotherapy, anti-human epidermal growth factor receptor 2 (HER2) therapy, and other targeted agents. Recently, everolimus, a mammalian target of rapamycin (mTOR) inhibitor, combined with exemestane, an...

Cite
Jerusalem G, Rorive A, Collignon J. Use of mTOR inhibitors in the treatment of breast cancer: an evaluation of factors that influence patient outcomes. Breast Cancer (Dove Med Press). 2014;6:43-57doi: 10.2147/BCTT.S38679.
Jerusalem, G., Rorive, A., & Collignon, J. (2014). Use of mTOR inhibitors in the treatment of breast cancer: an evaluation of factors that influence patient outcomes. Breast cancer (Dove Medical Press), 643-57. https://doi.org/10.2147/BCTT.S38679
Jerusalem, Guy, et al. "Use of mTOR inhibitors in the treatment of breast cancer: an evaluation of factors that influence patient outcomes." Breast cancer (Dove Medical Press) vol. 6 (2014): 43-57. doi: https://doi.org/10.2147/BCTT.S38679
Jerusalem G, Rorive A, Collignon J. Use of mTOR inhibitors in the treatment of breast cancer: an evaluation of factors that influence patient outcomes. Breast Cancer (Dove Med Press). 2014 Apr 17;6:43-57. doi: 10.2147/BCTT.S38679. eCollection 2014. PMID: 24833916; PMCID: PMC4000187.
Copy Download .nbib Format: NLM
Economic analysis of the breast cancer screening program used by the UK NHS: should the program be maintained?.

Breast cancer (Dove Medical Press)

Morton R, Sayma M, Sura MS.
PMID: 28392714
Breast Cancer (Dove Med Press). 2017 Mar 24;9:217-225. doi: 10.2147/BCTT.S123558. eCollection 2017.

INTRODUCTION: One key tool thought to combat the spiraling costs of late-stage breast cancer diagnosis is the use of breast cancer screening. However, over recent years, more effective treatments and questions being raised over the safety implications of using...

Cite
Morton R, Sayma M, Sura MS. Economic analysis of the breast cancer screening program used by the UK NHS: should the program be maintained?. Breast Cancer (Dove Med Press). 2017;9:217-225doi: 10.2147/BCTT.S123558.
Morton, R., Sayma, M., & Sura, M. S. (2017). Economic analysis of the breast cancer screening program used by the UK NHS: should the program be maintained?. Breast cancer (Dove Medical Press), 9217-225. https://doi.org/10.2147/BCTT.S123558
Morton, Robert, et al. "Economic analysis of the breast cancer screening program used by the UK NHS: should the program be maintained?." Breast cancer (Dove Medical Press) vol. 9 (2017): 217-225. doi: https://doi.org/10.2147/BCTT.S123558
Morton R, Sayma M, Sura MS. Economic analysis of the breast cancer screening program used by the UK NHS: should the program be maintained?. Breast Cancer (Dove Med Press). 2017 Mar 24;9:217-225. doi: 10.2147/BCTT.S123558. eCollection 2017. PMID: 28392714; PMCID: PMC5373833.
Copy Download .nbib Format: NLM
Effects of .

Breast cancer (Dove Medical Press)

Charoenchokthavee W, Areepium N, Panomvana D, Sriuranpong V.
PMID: 28450788
Breast Cancer (Dove Med Press). 2017 Apr 15;9:249-256. doi: 10.2147/BCTT.S125745. eCollection 2017.

No abstract available.

Cite
Charoenchokthavee W, Areepium N, Panomvana D, et al. Effects of . Breast Cancer (Dove Med Press). 2017;9:249-256doi: 10.2147/BCTT.S125745.
Charoenchokthavee, W., Areepium, N., Panomvana, D., & Sriuranpong, V. (2017). Effects of . Breast cancer (Dove Medical Press), 9249-256. https://doi.org/10.2147/BCTT.S125745
Charoenchokthavee, Wanaporn, et al. "Effects of ." Breast cancer (Dove Medical Press) vol. 9 (2017): 249-256. doi: https://doi.org/10.2147/BCTT.S125745
Charoenchokthavee W, Areepium N, Panomvana D, Sriuranpong V. Effects of . Breast Cancer (Dove Med Press). 2017 Apr 15;9:249-256. doi: 10.2147/BCTT.S125745. eCollection 2017. PMID: 28450788; PMCID: PMC5399972.
Copy Download .nbib Format: NLM
Drug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment response.

Breast cancer (Dove Medical Press)

Jernström S, Hongisto V, Leivonen SK, Due EU, Tadele DS, Edgren H, Kallioniemi O, Perälä M, Mælandsmo GM, Sahlberg KK.
PMID: 28356768
Breast Cancer (Dove Med Press). 2017 Mar 21;9:185-198. doi: 10.2147/BCTT.S115600. eCollection 2017.

BACKGROUND: Approximately 15%-20% of all diagnosed breast cancers are characterized by amplified and overexpressed HER2 (= ErbB2). These breast cancers are aggressive and have a poor prognosis. Although improvements in treatment have been achieved after the introduction of trastuzumab...

Cite
Jernström S, Hongisto V, Leivonen SK, et al. Drug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment response. Breast Cancer (Dove Med Press). 2017;9:185-198doi: 10.2147/BCTT.S115600.
Jernström, S., Hongisto, V., Leivonen, S. K., Due, E. U., Tadele, D. S., Edgren, H., Kallioniemi, O., Perälä, M., Mælandsmo, G. M., & Sahlberg, K. K. (2017). Drug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment response. Breast cancer (Dove Medical Press), 9185-198. https://doi.org/10.2147/BCTT.S115600
Jernström, Sandra, et al. "Drug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment response." Breast cancer (Dove Medical Press) vol. 9 (2017): 185-198. doi: https://doi.org/10.2147/BCTT.S115600
Jernström S, Hongisto V, Leivonen SK, Due EU, Tadele DS, Edgren H, Kallioniemi O, Perälä M, Mælandsmo GM, Sahlberg KK. Drug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment response. Breast Cancer (Dove Med Press). 2017 Mar 21;9:185-198. doi: 10.2147/BCTT.S115600. eCollection 2017. PMID: 28356768; PMCID: PMC5367762.
Copy Download .nbib Format: NLM
Safety and esthetic outcomes of therapeutic mammoplasty using medial pedicle for early breast cancer.

Breast cancer (Dove Medical Press)

Roshdy S, Hussein O, Khater A, Zuhdy M, El-Hadaad HA, Farouk O, Senbel A, Fathi A, Hamed E, Denewer A.
PMID: 26185469
Breast Cancer (Dove Med Press). 2015 Jul 07;7:173-8. doi: 10.2147/BCTT.S83725. eCollection 2015.

BACKGROUND: Although therapeutic mammoplasty (TM) was introduced for treatment of localized ductal carcinoma in situ and invasive breast carcinoma (stages I and II) in females with large breast size, the suitability of medial pedicle TM for treatment of breast...

Cite
Roshdy S, Hussein O, Khater A, et al. Safety and esthetic outcomes of therapeutic mammoplasty using medial pedicle for early breast cancer. Breast Cancer (Dove Med Press). 2015;7:173-8doi: 10.2147/BCTT.S83725.
Roshdy, S., Hussein, O., Khater, A., Zuhdy, M., El-Hadaad, H. A., Farouk, O., Senbel, A., Fathi, A., Hamed, E., & Denewer, A. (2015). Safety and esthetic outcomes of therapeutic mammoplasty using medial pedicle for early breast cancer. Breast cancer (Dove Medical Press), 7173-8. https://doi.org/10.2147/BCTT.S83725
Roshdy, Sameh, et al. "Safety and esthetic outcomes of therapeutic mammoplasty using medial pedicle for early breast cancer." Breast cancer (Dove Medical Press) vol. 7 (2015): 173-8. doi: https://doi.org/10.2147/BCTT.S83725
Roshdy S, Hussein O, Khater A, Zuhdy M, El-Hadaad HA, Farouk O, Senbel A, Fathi A, Hamed E, Denewer A. Safety and esthetic outcomes of therapeutic mammoplasty using medial pedicle for early breast cancer. Breast Cancer (Dove Med Press). 2015 Jul 07;7:173-8. doi: 10.2147/BCTT.S83725. eCollection 2015. PMID: 26185469; PMCID: PMC4500603.
Copy Download .nbib Format: NLM
Critical analysis of the potential for microRNA biomarkers in breast cancer management.

Breast cancer (Dove Medical Press)

Graveel CR, Calderone HM, Westerhuis JJ, Winn ME, Sempere LF.
PMID: 25759599
Breast Cancer (Dove Med Press). 2015 Feb 23;7:59-79. doi: 10.2147/BCTT.S43799. eCollection 2015.

Breast cancer is a complex and heterogeneous disease. Signaling by estrogen receptor (ER), progesterone receptor (PR), and/or human EGF-like receptor 2 (HER2) is a main driver in the development and progression of a large majority of breast tumors. Molecular...

Cite
Graveel CR, Calderone HM, Westerhuis JJ, et al. Critical analysis of the potential for microRNA biomarkers in breast cancer management. Breast Cancer (Dove Med Press). 2015;7:59-79doi: 10.2147/BCTT.S43799.
Graveel, C. R., Calderone, H. M., Westerhuis, J. J., Winn, M. E., & Sempere, L. F. (2015). Critical analysis of the potential for microRNA biomarkers in breast cancer management. Breast cancer (Dove Medical Press), 759-79. https://doi.org/10.2147/BCTT.S43799
Graveel, Carrie R, et al. "Critical analysis of the potential for microRNA biomarkers in breast cancer management." Breast cancer (Dove Medical Press) vol. 7 (2015): 59-79. doi: https://doi.org/10.2147/BCTT.S43799
Graveel CR, Calderone HM, Westerhuis JJ, Winn ME, Sempere LF. Critical analysis of the potential for microRNA biomarkers in breast cancer management. Breast Cancer (Dove Med Press). 2015 Feb 23;7:59-79. doi: 10.2147/BCTT.S43799. eCollection 2015. PMID: 25759599; PMCID: PMC4346363.
Copy Download .nbib Format: NLM
The predictors of poor quality of life in a sample of Saudi women with breast cancer.

Breast cancer (Dove Medical Press)

Ahmed AE, Alharbi AG, Alsadhan MA, Almuzaini AS, Almuzaini HS, Ali YZ, Jazieh AR.
PMID: 28223845
Breast Cancer (Dove Med Press). 2017 Feb 09;9:51-58. doi: 10.2147/BCTT.S125206. eCollection 2017.

BACKGROUND: The protocols for treatment, along with many adverse effects, can strongly affect cancer patients' quality of life (QoL). As there is limited research on the QoL of Saudi Arabian women being treated for breast cancer, the purpose of...

Cite
Ahmed AE, Alharbi AG, Alsadhan MA, et al. The predictors of poor quality of life in a sample of Saudi women with breast cancer. Breast Cancer (Dove Med Press). 2017;9:51-58doi: 10.2147/BCTT.S125206.
Ahmed, A. E., Alharbi, A. G., Alsadhan, M. A., Almuzaini, A. S., Almuzaini, H. S., Ali, Y. Z., & Jazieh, A. R. (2017). The predictors of poor quality of life in a sample of Saudi women with breast cancer. Breast cancer (Dove Medical Press), 951-58. https://doi.org/10.2147/BCTT.S125206
Ahmed, Anwar E, et al. "The predictors of poor quality of life in a sample of Saudi women with breast cancer." Breast cancer (Dove Medical Press) vol. 9 (2017): 51-58. doi: https://doi.org/10.2147/BCTT.S125206
Ahmed AE, Alharbi AG, Alsadhan MA, Almuzaini AS, Almuzaini HS, Ali YZ, Jazieh AR. The predictors of poor quality of life in a sample of Saudi women with breast cancer. Breast Cancer (Dove Med Press). 2017 Feb 09;9:51-58. doi: 10.2147/BCTT.S125206. eCollection 2017. PMID: 28223845; PMCID: PMC5308476.
Copy Download .nbib Format: NLM
[No title available]

Breast cancer (Dove Medical Press)

Wickramage I, Tennekoon KH, Ariyaratne MA, Hewage AS, Sundralingam T.
PMID: 28293118
Breast Cancer (Dove Med Press). 2017 Mar 06;9:111-120. doi: 10.2147/BCTT.S126557. eCollection 2017.

No abstract available.

Cite
Wickramage I, Tennekoon KH, Ariyaratne MA, et al. . Breast Cancer (Dove Med Press). 2017;9:111-120doi: 10.2147/BCTT.S126557.
Wickramage, I., Tennekoon, K. H., Ariyaratne, M. A., Hewage, A. S., & Sundralingam, T. (2017). . Breast cancer (Dove Medical Press), 9111-120. https://doi.org/10.2147/BCTT.S126557
Wickramage, Ishani, et al. "." Breast cancer (Dove Medical Press) vol. 9 (2017): 111-120. doi: https://doi.org/10.2147/BCTT.S126557
Wickramage I, Tennekoon KH, Ariyaratne MA, Hewage AS, Sundralingam T. . Breast Cancer (Dove Med Press). 2017 Mar 06;9:111-120. doi: 10.2147/BCTT.S126557. eCollection 2017. PMID: 28293118; PMCID: PMC5345689.
Copy Download .nbib Format: NLM
Factors affecting local recurrence and distant metastases of invasive breast cancer after breast-conserving surgery in Chiang Mai University Hospital.

Breast cancer (Dove Medical Press)

Ditsatham C, Somwangprasert A, Watcharachan K, Wongmaneerung P, Khorana J.
PMID: 27051315
Breast Cancer (Dove Med Press). 2016 Mar 18;8:47-52. doi: 10.2147/BCTT.S99184. eCollection 2016.

BACKGROUND: The purpose of this study was to collect data regarding breast cancer profiles and factors that affect local recurrence and distant metastasis after breast-conserving surgery (BCS) in Chiang Mai University Hospital.MATERIALS AND METHODS: This study was a retrospective...

Cite
Ditsatham C, Somwangprasert A, Watcharachan K, et al. Factors affecting local recurrence and distant metastases of invasive breast cancer after breast-conserving surgery in Chiang Mai University Hospital. Breast Cancer (Dove Med Press). 2016;8:47-52doi: 10.2147/BCTT.S99184.
Ditsatham, C., Somwangprasert, A., Watcharachan, K., Wongmaneerung, P., & Khorana, J. (2016). Factors affecting local recurrence and distant metastases of invasive breast cancer after breast-conserving surgery in Chiang Mai University Hospital. Breast cancer (Dove Medical Press), 847-52. https://doi.org/10.2147/BCTT.S99184
Ditsatham, Chagkrit, et al. "Factors affecting local recurrence and distant metastases of invasive breast cancer after breast-conserving surgery in Chiang Mai University Hospital." Breast cancer (Dove Medical Press) vol. 8 (2016): 47-52. doi: https://doi.org/10.2147/BCTT.S99184
Ditsatham C, Somwangprasert A, Watcharachan K, Wongmaneerung P, Khorana J. Factors affecting local recurrence and distant metastases of invasive breast cancer after breast-conserving surgery in Chiang Mai University Hospital. Breast Cancer (Dove Med Press). 2016 Mar 18;8:47-52. doi: 10.2147/BCTT.S99184. eCollection 2016. PMID: 27051315; PMCID: PMC4807892.
Copy Download .nbib Format: NLM
Role of natural herbs and phytochemicals to minimize tumor and economic burden in breast cancer treatment.

Breast cancer (Dove Medical Press)

Shoaib M, Ahmed SA.
PMID: 27994484
Breast Cancer (Dove Med Press). 2016 Dec 07;8:241-242. doi: 10.2147/BCTT.S125826. eCollection 2016.

No abstract available.

Cite
Shoaib M, Ahmed SA. Role of natural herbs and phytochemicals to minimize tumor and economic burden in breast cancer treatment. Breast Cancer (Dove Med Press). 2016;8:241-242doi: 10.2147/BCTT.S125826.
Shoaib, M., & Ahmed, S. A. (2016). Role of natural herbs and phytochemicals to minimize tumor and economic burden in breast cancer treatment. Breast cancer (Dove Medical Press), 8241-242. https://doi.org/10.2147/BCTT.S125826
Shoaib, Maria, and Ahmed, Syed Ahsanuddin. "Role of natural herbs and phytochemicals to minimize tumor and economic burden in breast cancer treatment." Breast cancer (Dove Medical Press) vol. 8 (2016): 241-242. doi: https://doi.org/10.2147/BCTT.S125826
Shoaib M, Ahmed SA. Role of natural herbs and phytochemicals to minimize tumor and economic burden in breast cancer treatment. Breast Cancer (Dove Med Press). 2016 Dec 07;8:241-242. doi: 10.2147/BCTT.S125826. eCollection 2016. PMID: 27994484; PMCID: PMC5153294.
Copy Download .nbib Format: NLM
Association between telomere length and CYP19 TTTA repetition polymorphism in healthy and breast cancer-diagnosed women.

Breast cancer (Dove Medical Press)

Murillo-Ortiz B, Martínez-Garza S, Suárez García D, Castillo Valenzuela RD, García Regalado JF, Cano Velázquez G.
PMID: 28144163
Breast Cancer (Dove Med Press). 2017 Jan 13;9:21-27. doi: 10.2147/BCTT.S125431. eCollection 2017.

INTRODUCTION: Several studies have reported an increase in breast cancer (BC) risk when patients are carriers of the CYP19 TTA polymorphism with ≥10 repeats; moreover, it has been reported that telomere length is associated with a higher susceptibility of...

Cite
Murillo-Ortiz B, Martínez-Garza S, Suárez García D, et al. Association between telomere length and CYP19 TTTA repetition polymorphism in healthy and breast cancer-diagnosed women. Breast Cancer (Dove Med Press). 2017;9:21-27doi: 10.2147/BCTT.S125431.
Murillo-Ortiz, B., Martínez-Garza, S., Suárez García, D., Castillo Valenzuela, R. D., García Regalado, J. F., & Cano Velázquez, G. (2017). Association between telomere length and CYP19 TTTA repetition polymorphism in healthy and breast cancer-diagnosed women. Breast cancer (Dove Medical Press), 921-27. https://doi.org/10.2147/BCTT.S125431
Murillo-Ortiz, Blanca, et al. "Association between telomere length and CYP19 TTTA repetition polymorphism in healthy and breast cancer-diagnosed women." Breast cancer (Dove Medical Press) vol. 9 (2017): 21-27. doi: https://doi.org/10.2147/BCTT.S125431
Murillo-Ortiz B, Martínez-Garza S, Suárez García D, Castillo Valenzuela RD, García Regalado JF, Cano Velázquez G. Association between telomere length and CYP19 TTTA repetition polymorphism in healthy and breast cancer-diagnosed women. Breast Cancer (Dove Med Press). 2017 Jan 13;9:21-27. doi: 10.2147/BCTT.S125431. eCollection 2017. PMID: 28144163; PMCID: PMC5245810.
Copy Download .nbib Format: NLM
Younger age is an independent predictor of worse prognosis among Lebanese nonmetastatic breast cancer patients: analysis of a prospective cohort.

Breast cancer (Dove Medical Press)

El Chediak A, Alameddine RS, Hakim A, Hilal L, Abdel Massih S, Hamieh L, Mukherji D, Temraz S, Charafeddine M, Shamseddine A.
PMID: 28670139
Breast Cancer (Dove Med Press). 2017 Jun 10;9:407-414. doi: 10.2147/BCTT.S130273. eCollection 2017.

BACKGROUND: Several retrospective studies have reported that younger age at presentation is associated with a worse prognosis for nonmetastatic breast cancer patients. In this study, we prospectively assessed the association between different baseline characteristics (age, tumor characteristics, mode of...

Cite
El Chediak A, Alameddine RS, Hakim A, et al. Younger age is an independent predictor of worse prognosis among Lebanese nonmetastatic breast cancer patients: analysis of a prospective cohort. Breast Cancer (Dove Med Press). 2017;9:407-414doi: 10.2147/BCTT.S130273.
El Chediak, A., Alameddine, R. S., Hakim, A., Hilal, L., Abdel Massih, S., Hamieh, L., Mukherji, D., Temraz, S., Charafeddine, M., & Shamseddine, A. (2017). Younger age is an independent predictor of worse prognosis among Lebanese nonmetastatic breast cancer patients: analysis of a prospective cohort. Breast cancer (Dove Medical Press), 9407-414. https://doi.org/10.2147/BCTT.S130273
El Chediak, Alissar, et al. "Younger age is an independent predictor of worse prognosis among Lebanese nonmetastatic breast cancer patients: analysis of a prospective cohort." Breast cancer (Dove Medical Press) vol. 9 (2017): 407-414. doi: https://doi.org/10.2147/BCTT.S130273
El Chediak A, Alameddine RS, Hakim A, Hilal L, Abdel Massih S, Hamieh L, Mukherji D, Temraz S, Charafeddine M, Shamseddine A. Younger age is an independent predictor of worse prognosis among Lebanese nonmetastatic breast cancer patients: analysis of a prospective cohort. Breast Cancer (Dove Med Press). 2017 Jun 10;9:407-414. doi: 10.2147/BCTT.S130273. eCollection 2017. PMID: 28670139; PMCID: PMC5479304.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 625 entries